Alnylam Pharmaceuticals, Inc. (LON:0HD2)
London · Delayed Price · Currency is GBP · Price in USD 404.03
+7.24 (1.83%)
At close: Dec 19, 2025
Alnylam Pharmaceuticals Market Cap
Alnylam Pharmaceuticals has a market cap or net worth of 39.54 billion as of December 19, 2025. Its market cap has increased by 53.01% in one year.
Market Cap
39.54B
Enterprise Value
39.57B
Revenue
2.39B
Ranking
n/a
PE Ratio
1,219.88
Stock Price
404.03
Market Cap Chart
Since May 28, 2004, Alnylam Pharmaceuticals's market cap has increased from 63.23M to 39.54B, an increase of 62,431.23%. That is a compound annual growth rate of 34.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 39.54B | 63.08% |
| Dec 31, 2024 | 24.24B | 28.56% |
| Dec 29, 2023 | 18.86B | -22.29% |
| Dec 30, 2022 | 24.27B | 62.00% |
| Dec 31, 2021 | 14.98B | 35.43% |
| Dec 31, 2020 | 11.06B | 14.08% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 212.02B |
| GSK plc | 73.11B |
| Haleon | 33.29B |
| Smith & Nephew | 10.48B |
| Convatec Group | 4.72B |
| Hikma Pharmaceuticals | 3.35B |
| HUTCHMED (China) | 1.71B |
| Genus | 1.71B |